Global Premature Ejaculation Treatment Market to grow at a CAGR of 9.65% during the period 2016 - 2020; Finds New Report

Report forecast the global premature ejaculation treatment market to grow at a CAGR of 9.65% during the period 2016-2020.

Premature ejaculation refers to the discharge of semen shortly before or after penetration during sexual intercourse, thereby leading to an unsatisfactory sex life and affecting the patient's relationship with their partner. There is no proper cause that can be associated with the condition. However, personal distress and anxiety are possible attributes.

The report covers the present scenario and the growth prospects of the global premature ejaculation treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of premature ejaculation drugs and premature ejaculation solutions.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

According to the report, high prevalence rate of cancer among men will be a key driver for market growth. Cancer is a probable cause of premature ejaculation among men. Cancer treatment can lead to a change in hormonal functioning and sex hormones (androgens such as testosterone), which eventually affects the libido and the ability of men to achieve orgasms during sexual intercourse. Generally, cancer requires treatments such as surgery, radiotherapy, and chemotherapy to completely eradicate the disease in the patient or to limit the spread of cancer cells. In many cases, chemotherapy among men has been known to impede the production of testosterone, thus affecting overall sexual response and desire. Therefore, the increase in the number of cases of cancer among men raises the probability of premature ejaculation cases.

Further, the report states that use of off-label drugs will be a challenge for the market. Many off-label drugs are used for premature ejaculation, including SSRIs such as Paroxetine, Sertraline, and Fluoxetine, and PDE5 inhibitors such as Cialis, Viagra, and Levitra. These drugs are not approved by the regulatory authority for the treatment of premature ejaculation. Though these drugs do not have an FDA-compliant indication for treating premature ejaculation, many online retail pharmacies are aggressively marketing them because many men affected by the condition are desperate for a solution in order to have sexual intercourse with normal latency. This is a challenge to the premature ejaculation treatment market because it is depleting the market share of approved therapies such as Promescent, Tempe, and Priligy.

Global Premature Ejaculation Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global premature ejaculation treatment market:  Absorption Pharmaceuticals, Allergan, Innovus Pharmaceuticals, and Plethora.

Other Prominent Vendors in the market are: Aytu BioScience, Bayer, Dong-A Pharmaceutical, Eli Lilly, Emcure, Futura Medical, GlaxoSmithKline, NeuroHealing Pharmaceuticals, and Pfizer.

Market driver

• Rise in number of erectile dysfunction cases
• For a full, detailed list, view our report

Market challenge

• Threat of alternative treatments
• For a full, detailed list, view our report

Market trend

• Increase in awareness of premature ejaculation
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 57 pages and 31 Exhibit “Global Premature Ejaculation Treatment Market 2016 - 2020” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Geographical segmentation, Market segmentation by route of administration, Market segmentation by mechanism of action, Market segmentation by off-label drugs, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://mrr.cm/JFb

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare